Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study

Maximilian J Mair; Manfred Mitterer; Margaretha Gansterer; Arne C Bathke; Wolfgang Trutschnig; Anna S Berghoff; Thomas Perkmann; Helmuth Haslacher; Wolfgang W Lamm; Markus Raderer; Selma Tobudic; Thorsten Fuereder; Thomas Buratti; Dominic Fong; Matthias Preusser

doi:10.1016/j.ejca.2022.01.019

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study

Maximilian J Mair, Manfred Mitterer, Margaretha Gansterer, Arne C Bathke, Wolfgang Trutschnig, Anna S Berghoff, Thomas Perkmann, Helmuth Haslacher, Wolfgang W Lamm, Markus Raderer, Selma Tobudic, Thorsten Fuereder, Thomas Buratti, Dominic Fong, Matthias Preusser

Artificial Intelligence and Human Interfaces

Publikation: Beitrag in Fachzeitschrift › Artikel › Peer-reviewed

Originalsprache	Englisch
Seiten (von - bis)	184-194
Seitenumfang	11
Fachzeitschrift	European Journal of Cancer
Jahrgang	165
Frühes Online-Datum	7 Feb. 2022
DOIs	https://doi.org/10.1016/j.ejca.2022.01.019
Publikationsstatus	Veröffentlicht - Apr. 2022

Bibliographische Notiz

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Funding Information:
This study was funded by the research budget of the Medical University of Vienna and the budget of the Südtiroler Sanitätsbetrieb. The funding organisations had no role/influence in design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.

Funding Information:
This study was funded by the research budget of the Medical University of Vienna and the budget of the S?dtiroler Sanit?tsbetrieb. The funding organisations had no role/influence in design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.Anna Sophie Berghoff has received research support from Daiichi Sankyo, Roche, and honoraria for lectures, consultation or advisory board participation from Roche, Bristol-Meyers Squibb, Merck, Daiichi Sankyo as well as travel support from Roche, Amgen and AbbVie.

Publisher Copyright:
© 2022 The Author(s)

Systematik der Wissenschaftszweige 2012

302 Klinische Medizin

Zugriff auf Dokument

10.1016/j.ejca.2022.01.019

Andere Dateien und Links

Dieses zitieren

Mair, M. J., Mitterer, M., Gansterer, M., Bathke, A. C., Trutschnig, W., Berghoff, A. S., Perkmann, T., Haslacher, H., Lamm, W. W., Raderer, M., Tobudic, S., Fuereder, T., Buratti, T., Fong, D., & Preusser, M. (2022). Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study. European Journal of Cancer, 165, 184-194. https://doi.org/10.1016/j.ejca.2022.01.019

@article{d0cd4d9dcd814491841d6b8aa7213864,

title = "Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study",

keywords = "COVID-19, Cancer, Oncology, SARS-CoV-2, Vaccination, Health Personnel, Humans, COVID-19/prevention & control, COVID-19 Vaccines/adverse effects, Retrospective Studies, Immunity",

author = "Mair, {Maximilian J} and Manfred Mitterer and Margaretha Gansterer and Bathke, {Arne C} and Wolfgang Trutschnig and Berghoff, {Anna S} and Thomas Perkmann and Helmuth Haslacher and Lamm, {Wolfgang W} and Markus Raderer and Selma Tobudic and Thorsten Fuereder and Thomas Buratti and Dominic Fong and Matthias Preusser",

year = "2022",

month = apr,

doi = "10.1016/j.ejca.2022.01.019",

language = "English",

volume = "165",

pages = "184--194",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Mair, MJ, Mitterer, M, Gansterer, M, Bathke, AC , Trutschnig, W, Berghoff, AS, Perkmann, T, Haslacher, H, Lamm, WW, Raderer, M, Tobudic, S, Fuereder, T, Buratti, T, Fong, D & Preusser, M 2022, 'Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study', European Journal of Cancer, Jg. 165, S. 184-194. https://doi.org/10.1016/j.ejca.2022.01.019

TY - JOUR

T1 - Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers

T2 - immune responses and adverse events - a retrospective cohort study

AU - Mair, Maximilian J

AU - Mitterer, Manfred

AU - Gansterer, Margaretha

AU - Bathke, Arne C

AU - Trutschnig, Wolfgang

AU - Berghoff, Anna S

AU - Perkmann, Thomas

AU - Haslacher, Helmuth

AU - Lamm, Wolfgang W

AU - Raderer, Markus

AU - Tobudic, Selma

AU - Fuereder, Thorsten

AU - Buratti, Thomas

AU - Fong, Dominic

AU - Preusser, Matthias

PY - 2022/4

Y1 - 2022/4

KW - COVID-19

KW - Cancer

KW - Oncology

KW - SARS-CoV-2

KW - Vaccination

KW - Health Personnel

KW - Humans

KW - COVID-19/prevention & control

KW - COVID-19 Vaccines/adverse effects

KW - Retrospective Studies

KW - Immunity

UR - http://www.scopus.com/inward/record.url?scp=85125522334&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/cbd70b04-35ec-3faa-8a1b-c6fd574023ce/

U2 - 10.1016/j.ejca.2022.01.019

DO - 10.1016/j.ejca.2022.01.019

M3 - Article

C2 - 35248840

SN - 0959-8049

VL - 165

SP - 184

EP - 194

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -